Since 1995, the Northwest Clinical Research Center has partnered with the pharmaceutical industry to conduct clinical research trials and is dedicated to providing quality medical treatment and patient safety. Each patient receives psychological assessments and health evaluations by our medical staff. Our specialty is psychiatry and the treatment of mood disorders.

Dr. Khan is a Board Certified Psychiatrist and Adjunct Professor of Psychiatry at Duke University School of Medicine. He is the Medical Director and Principal Investigator at NNWCRC.  Dr. Khan has been conducting clinical trials in the greater Seattle area since 1984 and founded NWCRC in 1995.

Doctor Khan and the team at NWCRC have been researching schizophrenia for many years. They have completed nearly 15 clinical trials studying different medications for use in the treatment of schizophrenia. Some of the medications he has studied include Zyprexa®, Risperdal®, Seroquel® and Abilify®.

Dr. Khan has published papers about schizophrenia in medical and psychiatric journals around the world. You can view an abstract of one of his publications by clicking on the link below.

Mortality risk in patients with schizophrenia participating in premarketing atypical antipsychotic clinical trials. Khan A, Schwartz K, Stern C, Redding N, Kolts RL, Brown WA, Robinson D. Journal of Clinical Psychiatry, 68(12): 1828-1833, 2007.
Click here to read article

Dr. Kipp is a Board Certified primary care physician and has provided care to patients for over 30 years. He is currently a medical sub-investigator and has contributed to over 65 clinical trials here at NWCRC. When asked about his work, he says, “I enjoy patient contact and knowing that I’m making a difference through research.”